arrow
S

Shawn P. Griffin

University of California System
H-index:7
Citation Count:128
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients

异基因干细胞移植受者接受预防性短疗程福司卡奈特治疗后快速清除HHV-6

2026-04-130
PREAI
Optimal Pharmacokinetic Sampling Strategy for Melphalan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
2026-02-030
PRE
Oncology pharmacist survey: Understanding task value and professional satisfaction

肿瘤科药师调查:理解任务价值与职业满意度

2026-02-010
PRE
Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation

急性髓系白血病伴浆细胞样分化的皮肤病变:双重身份还是活跃转化?

2026-02-010
OAAI
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7+3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

Venetoclax联合克拉屈滨、伊达比星、阿糖胞苷(CLIA-VEN)在 newly diagnosed acute myeloid leukaemia 患者中可带来更高的缓解率,且未增加毒性,优于常规7+3化疗方案。

2025-11-010
OAAI
Comprehensive Framework for Oncology Pharmacist-Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network

肿瘤学药师主导的静脉抗癌治疗患者教育综合框架:美国临床药学学会血液学/肿瘤学实践与研究网络的意见

2025-09-010
OAAI
R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma

R-DA-EPOCH 与 DA-EPOCH-R:化疗免疫疗法顺序对弥漫性大B细胞淋巴瘤患者治疗结局的影响

2025-06-230
OAAI
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation

布地奈德,添加到PTCy为基础的方案中,用于预防异基因干细胞移植后的急性胃肠道移植物抗宿主病

2025-01-080
PRE
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience

髓母细胞期CML患者的前期化疗强化: 单中心经验

2024-10-230
OAAI
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection

早期冠状病毒病2019感染的异基因干细胞移植患者免疫重建持续受损和生存结局恶化

2024-08-010
PRE
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation
2024-07-110
OAAI
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
2023-06-019
OAAI
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia
2023-02-242
OA
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch
2022-09-147
PRE
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
2020-05-082
OAAI